Morningstar3d
Elevance Health Expects Higher Revenue, Profit in 2025
Elevance Health topped profit and revenue expectations for the fourth quarter and is guiding for more gains from premiums and products in the year ahead. The health insurer formerly known as ...
Elevance Health Inc. stock underperforms Tuesday when compared to competitors
Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.
Morningstar2d
Elevance Health Raises Quarterly Dividend by 4.9% to $1.71
Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an ...
Elevance Health (ELV) Receives a Buy from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a
Wall Street Journal2d
Elevance Earnings: Stock Rises After Results, Guidance Match Expectations
Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), Intuitive Surgical (ISRG) and Walgreens Boots Alliance (WBA)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elevance Health (ELV – Research Report), Intuitive Surgical
Self Employed on MSN1d
US stocks see mixed premarket signals
US stocks showed mixed signals in premarket trading on Thursday. Futures for the S&P 500 lost 0.1% before the opening bell, while futures for the Dow Jones Industrial Average rose 0.1%. Shares of major US airlines fell after American Airlines posted strong profits but anticipated a loss in the first quarter.
Hosted on MSN1d
Dow Jones Falls After Inflation Data; 5 Tech Giants To Buy And Watch
The Dow Jones fell Friday ahead of inflation data. Amazon, Broadcom, Meta and Netflix are among the best stocks to buy and watch.
Barclays Remains a Buy on Elevance Health (ELV)
In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price
Elevance Health price target raised to $512 from $501 at Barclays
Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4
Dow Jones Today: Stocks Surge in Late Trading to Extend Winning Streak; S&P 500 Hits Record Closing High
Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.
Morningstar4d
Elevance Health Inc ELV
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...